INCIDENCE OF RECTAL CANCER IN THE POPULATION OF THE MOSCOW REGION IN 2010–2014

Cover Page


Cite item

Full Text

Abstract

Background: The incidence of colorectal cancer ranks the third among all cancer incidence rates. Rectal neoplasms are frequently considered as a separate nosological entity. The incidence of rectal cancer (RC) can be influenced by patient age, gender, lifestyle, diet, genetic factors, as well as by the organization and quality of preventive activities in medical institutions focused on the early cancer diagnosis. Aim: To study changes in RC incidence among residents of the Moscow Region from 2010 to 2014. Materials and methods: The incidence rate of RC was estimated based on the state statistical report data on newly diagnosed cancers in the population of the Moscow Region in 2010–2014. The intensive incidence rates were calculated per 100,000 of respective population in six age and gender groups. Results: From 2010 to 2014, 6079 new RC cases were identified in the Moscow Region, among them 47% men and 53% women. More than half of all RC cases were in the age group of 60 to 79 years old (61.7% of men and 59.2% of women). During the 5-year period, the incidence rate of RC decreased from 18.3 to 17 per 100,000 of the male population and increased from 15.7 to 17.5 per 100,000 among the female population. There was a clear correlation between the RC incidence and the patient age. The peak incidence in men and women was seen in the age group of 70 to 79 years. From the age group of 50 to 59 years and on, the incidence of RC in men was higher than that in women. Conclusion: The results of this study can be used to optimize activities in the public healthcare system aimed at reduction of morbidity and mortality related to RC. Among the priority actions should be allocated to the development and implementation of primary prevention measures, in particular, undergo screening tests (fecal occult blood test or colonoscopy) in age groups at high risk.

About the authors

A. S. Balkanov

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Author for correspondence.
Email: andreybalkanov@yandex.ru
MD, PhD, Head of Department of Radiology Россия

A. N. Gurov

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: angurov1@mail.ru
MD, PhD, Professor, Head of Department of Science and Organization Россия

N. A. Katuntseva

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: andreybalkanov@yandex.ru
MD, PhD, Head of Department of Public Health Problems and Regional Healthcare Programs Россия

E. A. Belousova

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: andreybalkanov@yandex.ru
MD, PhD, Professor, Head of Department of Gastroenterology Россия

References

  1. Гуров АН, Балканов АС, Катунцева НА, Огнева ЕЮ. Анализ онкозаболеваемости и смертности населения Московской области за 2014 год. Альманах клинической медицины. 2015;41:6–11. doi: 10.18786/2072-0505-2015-41-6-11.
  2. Phipps AI, Scoggins J, Rossing MA, Li CI, Newcomb PA. Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975–2007. Am J Public Health. 2012;102(9): 1791–7. doi: 10.2105/ AJPH.2011.300393.
  3. Ait Ouakrim D, Lockett T, Boussioutas A, Keogh L, Flander LB, Winship I, Giles GG, Hopper JL, Jenkins MA. Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer. Cancer Causes Control. 2012;23(11): 1853–64. doi: 10.1007/s10552-012-0067-y.
  4. Austin H, Henley SJ, King J, Richardson LC, Eheman C. Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening. Cancer Causes Control. 2014;25(2): 191–201. doi: 10.1007/s10552-013-0321-y.
  5. Myers EA, Feingold DL, Forde KA, Arnell T, Jang JH, Whelan RL. Colorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions' experience. World J Gastroenterol. 2013;19(34): 5651–7. doi: 10.3748/wjg.v19.i34.5651.
  6. Brooke HL, Talbäck M, Martling A, Feychting M, Ljung R. Socioeconomic position and incidence of colorectal cancer in the Swedish population. Cancer Epidemiol. 2016;40:188–95. doi: 10.1016/j.canep.2016.01.004.
  7. Simon MS, Thomson CA, Pettijohn E, Kato I, Rodabough RJ, Lane D, Hubbell FA, O'Sullivan MJ, Adams-Campbell L, Mouton CP, Abrams J, Chlebowski RT. Racial differences in colorectal cancer incidence and mortality in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2011;20(7): 1368–78. doi: 10.1158/1055-9965. EPI-11-0027.
  8. Raskov H, Pommergaard HC, Burcharth J, Rosenberg J. Colorectal carcinogenesis – update and perspectives. World J Gastroenterol. 2014;20(48): 18151–64. doi: 10.3748/wjg.v20. i48.18151.
  9. Shroff J, Thosani N, Batra S, Singh H, Guha S. Reduced incidence and mortality from col-orectal cancer with flexible-sigmoidoscopy screening: a meta-analysis. World J Gastroenterol. 2014;20(48): 18466–76. doi: 10.3748/wjg. v20.i48.18466.
  10. Lieberman DA, Williams JL, Holub JL, Morris CD, Logan JR, Eisen GM, Carney P. Race, ethnicity, and sex affect risk for polyps > 9 mm in average-risk individuals. Gastroenterology. 2014;147(2): 351–8. doi: 10.1053/j.gas-tro.2014.04.037.
  11. McClellan DA, Ojinnaka CO, Pope R, Simmons J, Fuller K, Richardson A, Helduser JW, Nash P, Ory MG, Bolin JN. Expanding access to colorectal cancer screening: benchmarking quality indicators in a Primary Care Colonoscopy Program. J Am Board Fam Med. 2015;28(6): 713–21. doi: 10.3122/jabfm.2015.06.140342.
  12. Rahman R, Schmaltz C, Jackson CS, Simoes EJ, Jackson-Thompson J, Ibdah JA. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States. Cancer Med. 2015;4(12): 1863–70. doi: 10.1002/cam4.560.
  13. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18(6): 1695–8. doi: 10.1158/1055-9965.EPI-09-0186.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Balkanov A.S., Gurov A.N., Katuntseva N.A., Belousova E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies